SPC243
Rúcaparíbkamsýlat
Status:
VeittApplication date:
22.11.2018Application published:
15.12.2018Grant published:
15.9.2020
Max expiry date:
28.5.2033Medicine name:
RubracaMedicine for children:
No
Timeline
Today
22.11.2018Application
15.12.2018Publication
15.9.2020Registration
28.5.2033Expires
Marketing license
IS authorization number:
EU/1/17/1250/001; EU/1/17/1250/002; EU/1/17/1250/003Date:
5.6.2018
Foreign authorization number:
EU/1/17/1250Date:
24.5.2018
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2534153